Hersh EM, Bodey GP, Nies BA, Freireich EJ. Cause of death in acute leukemia: a ten year study on 414 patients from 1954–1963. JAMA 1965;193:99–103.10.1001/jama.1965.03090020019005Search in Google Scholar
Han T, Stutzman L, Cohen E, Kim V. Effect of platelet transfusion on hemorrhage in patients with acute leukemia. An autopsy study. Cancer 1966;19:1937–42.10.1002/1097-0142(196612)19:12<1937::AID-CNCR2820191221>3.0.CO;2-GSearch in Google Scholar
Freireich EJ, Kilman A, Gaydos LA, et al. Response to repeated platelet transfusion from the same donor. Ann Int Med 1963;59:277–87.10.7326/0003-4819-59-3-277Search in Google Scholar
Lee EJ. Indications for platelet transfusion therapy. In: Clinical decisions in platelet therapy. Kurtz SA, Brubaker DB, eds. Bethesda, MD: American Association of Blood Banks, 1992:19–30.Search in Google Scholar
Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962;266:905–9.10.1056/NEJM196205032661802Search in Google Scholar
Belt RJ, Leite C, Haas CD, Stephens RL. Incidence of hemorrhagic complications in patients with cancer. JAMA 1978;239:2571–4.10.1001/jama.239.24.2571Search in Google Scholar
Dutcher JP, Schiffer CA, Aisner J, et al. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumor. Cancer 1984;67:13–22.10.1002/1097-0142(19840201)53:3<557::AID-CNCR2820530331>3.0.CO;2-7Search in Google Scholar
Beutler E. Platelet transfusions: the 20,000 μL trigger. Blood 1993;81:1411–3.10.1182/blood.V81.6.1411.1411Search in Google Scholar
Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Hematol 1978;7:523–40.10.1016/S0308-2261(21)00047-3Search in Google Scholar
Alvarado J, Djerassi I, Farber S. Transfusion of fresh, concentrated platelets to children with acute leukemia. J Ped 1965;67:13–22.10.1016/S0022-3476(65)80298-0Search in Google Scholar
Djerassi I, Farber S, Evans AE. Transfusion of fresh platelet concentrates to patients with secondary thrombocytopenia. N Engl J Med 1963;268:221–6.10.1056/NEJM196301312680501Search in Google Scholar
Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995;35:498–502.10.1046/j.1537-2995.1995.35695288769.xSearch in Google Scholar
Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 1991;338:1223–6.10.1016/0140-6736(91)92098-MSearch in Google Scholar
Strauss RA. Clinical perspectives of platelet transfusions: defining the optimal dose. J Clinical Apheresis 1995;10:124–7.10.1002/jca.29201003058582893Search in Google Scholar
Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;56:1105–9.Search in Google Scholar
Norol F, Duedari N, Kuentz M, et al. Comparison of different doses of platelet transfusion (abstract). Blood 1995;86 (suppl):353a.Search in Google Scholar
Herman JH, Klumpp TR, Christman RA, et al. The effect of platelet dose on the outcome of prophylactic platelet transfusion (abstract). Transfusion 1995;35(suppl):46S.Search in Google Scholar
Daly PA, Schiffer CA, Aisner J, Wiemik P. Platelet transfusion therapy: 1-hour post-transfusion increments are valuable in predicting the need for HLA initial preparation. JAMA 1980;243:435–8.10.1001/jama.1980.03300310023016Search in Google Scholar
Hogge DE, Dutcher JP, Aisner JP, et al. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363–9.10.1002/ajh.28301404076859034Search in Google Scholar
Kickler TS, Braine HG, Ness PM. The predictive value of crossmatching platelet transfusion for alloimmunized patients. Transfusion 1985;25:385–90.10.1046/j.1537-2995.1985.25485273823.x4024239Search in Google Scholar
